About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Signup For Free
Prilenia and Ferrer Announce Phase 3 ALS Study of Pridopidine at NEALS 2025
Prilenia Therapeutics and Ferrer announced the presentation of their planned pivotal Phase 3 study of pridopidine in Amyotrophic Lateral Sclerosis (AL...
© 2025 Pienomial. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
Prilenia and Ferrer Announce Phase 3 ALS Study of Pridopidine at NEALS 2025